SUPN
SUPN
NASDAQ · Pharmaceuticals

Supernus Pharmaceuticals Inc

Mid-Cap Stocks Pharmaceutical Stocks Healthcare Stocks
$50.06
+0.68 (+1.38%)
As of Mar 25, 10:00 PM ET ·
Analyst Consensus
Strong Buy
12
Analysts
Moderate
Coverage
Buy 10 83%
Hold 2 17%
Sell 0 0%
Price Target
Analyst Price Target +81.4% upside
Low Target $64.19
Average Target $90.83
High Target $118.96
Current Price $50.06
Current
$50.06
Target
$90.83
$64.19 $90.83 avg $118.96
Scenario Analysis
Bear Case
$64.19
28.2%
Low target
Base Case
$90.83
+81.4%
Avg target
Bull Case
$118.96
+137.6%
High target
Risk/Reward
4.9x
Highly favorable
Price in Context
52-Week High
$59.68
-16.1% from high
52-Week Low
$29.16
+71.7% from low
50-Day SMA
$49.76
+0.6% vs SMA
200-Day SMA
$43.00
+16.4% vs SMA
RSI (14)
59.9
Neutral
Target vs 52W High
$90.83
+52.2% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
 Strong Buy 39 77% $1,330.33 +45.2%
JNJ
Johnson & Johnson
 Buy 32 59% $299.55 +24.8%
MRK
Merck & Co. Inc.
 Buy 36 67% $159.27 +33.4%
PFE
Pfizer Inc.
 Hold 35 40% $33.90 +24.3%
BMY
Bristol-Myers Squibb Co
 Hold 36 42% $174.50 +196.1%
ZTS
Zoetis Inc
 Buy 25 64% $209.87 +79.8%
RPRX
Royalty Pharma Plc- Cl A
 Strong Buy 16 88% $36.26 -22.9%
VTRS
Viatris Inc
 Buy 18 67% $122.82 +809.8%